Medcura Closes $22.4 Million Financing to Accelerate Development of Surgical Hemostatic Gel and Surgical Hemostasis Portfolio View more
Medcura Inc. Appoints Jacob Rodman to Board of Directors, Preparing for LifeGel™ Flowable Hemostat Launch and Expanding Market Reach View more